OLD National Bancorp IN Has $699,000 Stake in Colgate-Palmolive (NYSE:CL)

OLD National Bancorp IN reduced its holdings in Colgate-Palmolive (NYSE:CL) by 14.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,688 shares of the company’s stock after selling 1,331 shares during the quarter. OLD National Bancorp IN’s holdings in Colgate-Palmolive were worth $699,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CL. Algert Global LLC boosted its holdings in Colgate-Palmolive by 14.4% in the second quarter. Algert Global LLC now owns 5,131 shares of the company’s stock valued at $498,000 after acquiring an additional 647 shares during the last quarter. Sanctuary Advisors LLC acquired a new position in shares of Colgate-Palmolive in the 2nd quarter valued at $8,904,000. Czech National Bank increased its position in shares of Colgate-Palmolive by 6.5% in the 3rd quarter. Czech National Bank now owns 166,449 shares of the company’s stock valued at $17,279,000 after buying an additional 10,106 shares in the last quarter. Canandaigua National Bank & Trust Co. raised its stake in Colgate-Palmolive by 1.8% during the 3rd quarter. Canandaigua National Bank & Trust Co. now owns 12,122 shares of the company’s stock worth $1,258,000 after buying an additional 211 shares during the period. Finally, Park Avenue Securities LLC grew its stake in Colgate-Palmolive by 38.3% in the third quarter. Park Avenue Securities LLC now owns 10,705 shares of the company’s stock valued at $1,111,000 after acquiring an additional 2,966 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Down 4.7 %

Colgate-Palmolive stock opened at $86.64 on Friday. Colgate-Palmolive has a fifty-two week low of $82.68 and a fifty-two week high of $109.30. The firm has a market capitalization of $70.78 billion, a PE ratio of 24.82, a P/E/G ratio of 3.70 and a beta of 0.44. The company’s 50-day moving average is $91.52 and its 200-day moving average is $97.25. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 405.81% and a net margin of 14.27%. During the same period last year, the business earned $0.87 EPS. Sell-side analysts anticipate that Colgate-Palmolive will post 3.58 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be issued a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.31%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.34% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently commented on CL. UBS Group dropped their price target on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research report on Thursday, January 16th. JPMorgan Chase & Co. cut their price target on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research note on Thursday, January 16th. TD Cowen lowered their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Finally, Barclays dropped their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive currently has an average rating of “Hold” and a consensus target price of $102.00.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.